Delivery Order SPE2DB22D1017-SPE2DB24FF4AC
- Not listed
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract has a potential value of $1,068.84 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and there is no set-aside designation. This award is a task order under a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The delivery order has a ceiling value of $2,579.44 and a period of performance through April 1, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a leading global pharmaceutical distributor, to provide Lantus SoloStar 100 unit/mL 3 mL insulin pens. The delivery order has a ceiling value of $2,544.38 and a period of performance through March 25, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lantus SoloStar 100 unit/mL 3mL insulin pens. The $1,511.42 contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. This delivery order is being issued under an indefinite delivery contract (IDC) with a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, for the supply of Lantus Solostar insulin pens. The contract has a completion date of February 28, 2024 and a potential value of $3,405.40. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that serves as a prime contractor providing a wide range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a completion date of February 27, 2024 and a potential value of $4,202.62. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor for this delivery order, which is...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a ceiling value of $2,858.05 and a performance period through May 31, 2022. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Lantus Solostar insulin pens, a specialty brand name medication, with a ceiling value of $1,187.60 and a period of performance through March 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation. The $3,562.80 contract is for the provision of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This delivery order is placed under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The $3,133.80 firm-fixed-price contract has a completion date of December 13, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4ACDelivery Order
This is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract, valued at $1,363.40, has a period of performance through March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/11/24 |